Yellow Fever in Africa: Estimating the Burden of Disease and Impact of Mass Vaccination from Outbreak and Serological Data

Neil Ferguson and colleagues estimate the disease burden of yellow fever in Africa, as well as the impact of mass vaccination campaigns. Please see later in the article for the Editors' Summary

• Publication year

  2014

• Venue

  PLoS Medicine

• Publication date

  2014-05-01

• Fields of study

  Medicine, Environmental Science

• Identifiers
  DOI 10.1371/journal.pmed.1001638PMID 24800812PMCID 4011853
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The whole iceberg: estimating the incidence of yellow fever virus infection from the number of severe cases.

  2014cited by this paper
• The estimated mortality impact of vaccinations forecast to be administered during 2011-2020 in 73 countries supported by the GAVI Alliance.

  2013cited by this paper
• Vaccines and vaccination against yellow fever. WHO position paper -- June 2013.

  2013cited by this paper
• Estimating Air Temperature and Its Influence on Malaria Transmission across Africa

  2013cited by this paper
• [Long term persistence of yellow fever neutralising antibodies in elderly persons].

  2011cited by this paper
• Persistance à long terme des anticorps neutralisants de la fièvre jaune chez les personnes âgées de 60 ans et plus

  2011cited by this paper
• Measuring the burden of arboviral diseases: the spectrum of morbidity and mortality from four prevalent infections

  2011cited by this paper
• Handbook of Markov Chain Monte Carlo

  2011cited by this paper
• The revised global yellow fever risk map and recommendations for vaccination, 2010: consensus of the Informal WHO Working Group on Geographic Risk for Yellow Fever.

  2011cited by this paper
• Assessment of Yellow Fever Epidemic Risk: An Original Multi-criteria Modeling Approach

  2009cited by this paper
• Seroprevalence and distribution of Flaviviridae, Togaviridae, and Bunyaviridae arboviral infections in rural Cameroonian adults.

  2006cited by this paper
• LandScan : A Global Population Database for Estimating Populations at Risk

  2006cited by this paper
• The global distribution of yellow fever and dengue.

  2006cited by this paper
• Published online in Wiley InterScience (www.interscience.wiley.com). DOI: 10.1002/joc.1276 VERY HIGH RESOLUTION INTERPOLATED CLIMATE SURFACES FOR GLOBAL LAND AREAS

  2005cited by this paper
• Yellow fever vaccine

  2005cited by this paper
• Yellow Fever: The Recurring Plague

  2004cited by this paper
• Yellow fever vaccine. WHO position paper.

  2003cited by this paper
• A solution to the problem of separation in logistic regression

  2002cited by this paper
• Yellow fever: an update.

  2001cited by this paper
• An empirical malaria distribution map for West Africa

  2001cited by this paper
• Shortage of vaccines during a yellow fever outbreak in Guinea.

  2001cited by this paper
• [Reemergence of yellow fever in West Africa: lessons from the past, advocacy for a control program].

  1999cited by this paper
• First recorded outbreak of yellow fever in Kenya, 1992-1993. II. Entomologic investigations.

  1998cited by this paper
• Re-emergence of yellow fever in Senegal in 1995.

  1998cited by this paper
• First recorded outbreak of yellow fever in Kenya, 1992-1993. I. Epidemiologic investigations.

  1998cited by this paper
• The IGBP-DIS global 1 km land cover data set

  1997cited by this paper
• The IGBP-DIS global 1km land cover data set, DISCover: First results

  1997cited by this paper
• Markov chain Monte Carlo in Practice

  1996cited by this paper
• Analyses of Global Monthly Precipitation Using Gauge Observations, Satellite Estimates, and Numerical Model Predictions

  1996cited by this paper
• Should yellow fever vaccine be included in the expanded program of immunization in Africa? A cost-effectiveness analysis for Nigeria.

  1993cited by this paper
• Yellow fever haemagglutination-inhibiting, neutralising and IgM antibodies in vaccinated and unvaccinated residents of Ibadan, Nigeria.

  1990cited by this paper
• Yellow fever in 1988.

  1990cited by this paper
• Urban yellow fever epidemic in western Nigeria, 1987.

  1989cited by this paper
• Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach.

  1988cited by this paper
• Epidemic yellow fever in eastern Nigeria, 1986.

  1988cited by this paper
• Investigation of a possible yellow fever epidemic and serosurvey for flavivirus infections in northern Cameroon, 1984.

  1987cited by this paper
• Prevention and control of yellow fever in Africa

  1987cited by this paper
• [Evaluation of immunological and entomotological indices of yellow fever in Pointe-Noire, People's Republic of Congo].

  1986cited by this paper
• [Prevalence of yellow fever antibodies in north Zaire].

  1985cited by this paper
• The Expanded Programme on Immunization of the World Health Organization.

  1984cited by this paper
• Persistence of neutralizing antibody 30-35 years after immunization with 17D yellow fever vaccine.

  1981cited by this paper
• Yellow fever in the Gambia, 1978--1979: epidemiologic aspects with observations on the occurrence of orungo virus infections.

  1980cited by this paper
• Estimating the Dimension of a Model

  1978influential reference
• Yellow Fever Vaccine. II. Antigenicity and Neurovirulence of a Vaccine Seed Free from Avian Leukosis Virus

  1969cited by this paper
• THE WORLD HEALTH ORGANIZATION

  1954cited by this paper
• On epidemic yellow fever

  year unknowncited by this paper

• Low-dose yellow fever vaccination in infants: a randomised, double-blind, non-inferiority trial.

  2026cites this paper
• Interplay between flaviviruses and the interferon response: mechanisms of immune evasion and therapeutic implications.

  2026cites this paper
• Yellow Fever in Buenos Aires

  2026cites this paper
• Substitutions M478K and A482G in the polymerase of yellow fever virus confer resistance to sofosbuvir and uprifosbuvir in vitro.

  2026cites this paper
• Arboviruses circulation in Guinea: Overview and perspectives for public health

  2026cites this paper
• Mathematical model of yellow fever transmission dynamics with human hosts and incorporating seasonally varying mosquito recruitment

  2026cites this paper
• Potential pandemic: Biothermodynamic analysis of the Yellow fever virus-host interaction

  2026cites this paper
• NS5-targeting nucleoside analogs inhibit dengue virus and other flaviviruses.

  2026cites this paper
• The Yellow Fever Vaccine Journey: Milestones and Future Directions

  2026cites this paper
• Low-Dose Yellow Fever Vaccine in Adults in Africa

  2025cites this paper
• A century of emergence: trends and patterns in human viral pathogens, 1900–2024, a systematic review

  2025cites this paper
• Analysis of Morbidity and Mortality Due to Yellow Fever in Brazil

  2025cites this paper
• Re‐emergence of Aedes aegypti (Linnaeus) in Egypt: Predicting distribution shifts under climate changes

  2025cites this paper
• RSero: A user-friendly R package to reconstruct pathogen circulation history from seroprevalence studies

  2025cites this paper
• Fieber bei Reiserückkehrern

  2025cites this paper
• Modes of action of a small molecule antiviral compound targeting yellow fever virus NS4B protein

  2025cites this paper
• Nucleic Acid Based Detection and Prevalence of Yellow Fever Viral RNA Among Mosquitoes in Bayelsa State, Nigeria: An Environmental Epithet of Emerging Water‐Inhabiting Insects

  2025cites this paper
• Two mutations in NS2B are responsible for attenuation of the yellow fever virus (YFV) vaccine strain 17D

  2025cites this paper
• Epidemic Outbreaks Related to Yellow Fever Viruses.

  2025cites this paper
• Community perceptions of yellow fever and its treatment practices in regions with reported outbreaks in Uganda: A qualitative study

  2025cites this paper
• Reemergencia de la Fiebre Amarilla en Colombia, Expansión Geográfica e Impacto en Poblaciones Vulnerables

  2025cites this paper
• A single residue in the yellow fever virus envelope protein modulates virion architecture and antigenicity

  2025cites this paper
• Building resilience against the growing threat of arboviruses: a scoping review of Aedes vector surveillance, control strategies and insecticide resistance in Africa

  2025cites this paper
• Aedes mosquito distribution across urban and peri-urban areas of Kinshasa city, Democratic Republic of Congo

  2025cites this paper
• Yellow fever in plain sight: assessing disease surveillance officers’ knowledge and self-efficacy in identification and reporting in Kwara State, Nigeria

  2025cites this paper
• Plaque reduction neutralization test (PRNT50) for the detection of anti-yellow fever antibodies from clinical samples.

  2025cites this paper
• The Incidence and Trends of Yellow Fever from 1990 to 2021 in Major Endemic Regions: A Systematic Analysis Based on the 2021 Global Burden of Disease Study

  2025cites this paper
• Significance of vertical transmission of arboviruses in mosquito-borne disease epidemiology

  2025cites this paper
• A Systematic Review on the Utility of Wastewater Surveillance for Monitoring Yellow Fever Virus and Other Arboviruses.

  2025cites this paper
• The overlapping global distribution of dengue, chikungunya, Zika and yellow fever

  2025cites this paper
• The Use of Residual Blood Specimens in Seroprevalence Studies for Vaccine-Preventable Diseases: A Scoping Review

  2025cites this paper
• Mesenteric ischemia and bacterial translocation precipitate the intoxication phase of yellow fever

  2025cites this paper
• Exploring the national burden and challenges in the fight against yellow fever in the Democratic Republic of Congo: a review

  2025cites this paper
• Exploring the impact of vaccination coverage on yellow fever incidence: a country-level analysis of lagged effects in South America (2015–2023)

  2025cites this paper
• Breakthroughs and insights: A comprehensive review of yellow fever vaccine breakthrough infection across 8 decades.

  2024cites this paper
• Evaluation of Yellow Fever Virus Infection in Aedes aegypti Mosquitoes from Pakistan with Distinct Knockdown Resistance Genotypes

  2024cites this paper
• Introduction aux arboviroses

  2024cites this paper
• Development of a hydrogen peroxide-inactivated vaccine that protects against viscerotropic yellow fever in a non-human primate model

  2024cites this paper
• Viral hijacking of hnRNPH1 unveils a G-quadruplex-driven mechanism of stress control.

  2024cites this paper
• Impact of HIV-Related Immune Impairment of Yellow Fever Vaccine Immunogenicity in People Living with HIV—ANRS 12403

  2024cites this paper
• Durable cellular immune response against inactivated ZIKV and envelope proteins in ZIKV-infected women during pregnancy

  2024cites this paper
• Systems Immunology Approaches to Understanding Immune Responses in Acute Infection of Yellow Fever Patients

  2024cites this paper
• YF17D‐based vaccines – standing on the shoulders of a giant

  2024cites this paper
• Identifying and reducing risks of neurological complications associated with vaccination

  2024cites this paper
• Cynomolgus macaques as a translational model of human immune responses to yellow fever 17D vaccination

  2024cites this paper
• The luminescent principle and sensing mechanism of metal-organic framework for bioanalysis and bioimaging.

  2024cites this paper
• Seroprevalence of dengue, yellow fever, and related flaviviruses among the rural human population in Nguruman and Kerio Valley, Kenya

  2024cites this paper
• Mosquito-borne diseases: assessing risk and strategies to control their spread in the Middle East

  2024cites this paper
• The global incidence and trends of three common flavivirus infections (Dengue, yellow fever, and Zika) from 2011 to 2021

  2024cites this paper
• Neglected and Emerging Infections of The Kidney.

  2024cites this paper
• Monoclonal antibody applications in travel medicine

  2024cites this paper
• Yellow fever vaccine coverage and associated factors among under-five children in Kenya: Data from Kenyan Demographic and Health Survey 2022

  2024cites this paper
• Nationwide Inventory of Mosquitoes and the Distribution of Invasive Aedes (Stegomyia) albopictus (Skuse, 1894) on the Islands of Sao Tome and Principe in Central Africa

  2024cites this paper
• Genome-wide CRISPR screens and their applications in infectious disease

  2023cites this paper
• A Bioreactor-Based Yellow Fever Virus-like Particle Production Process with Integrated Process Analytical Technology Based on Transient Transfection

  2023cites this paper
• YF17D-vectored Ebola vaccine candidate protects mice against lethal surrogate Ebola and yellow fever virus challenge

  2023cites this paper
• From serological surveys to disease burden: a modelling pipeline for Chagas disease

  2023cites this paper
• Sustainable Development Goal Halftime Project: Benefit-Cost Analysis Using Methods from the Decade of Vaccine Economics Model

  2023cites this paper
• Current Status of Omics Studies Elucidating the Features of Reproductive Biology in Blood-Feeding Insects

  2023cites this paper
• Mosquito gene targeted RNAi studies for vector control

  2023cites this paper
• Performance assessment and validation of a plaque reduction neutralization test (PRNT) in support to yellow fever diagnostic and vaccine clinical trials

  2023cites this paper
• The impact of mortality underreporting on the association of ambient temperature and PM10 with mortality risk in time series study.

  2023cites this paper
• Flaviviruses & the Traveler: Around the World and to Your Stage.

  2023cites this paper
• A systematic review of the data, methods and environmental covariates used to map Aedes-borne arbovirus transmission risk

  2023cites this paper
• Immunogenicity and safety of fractional doses of 17D-213 yellow fever vaccine in HIV-infected people in Kenya (YEFE): a randomised, double-blind, non-inferiority substudy of a phase 4 trial

  2023cites this paper
• Niche and Range Shifts of Aedes aegypti and Ae. albopictus Suggest That the Latecomer Shows a Greater Invasiveness

  2023cites this paper
• Single-dose YF17D-vectored Ebola vaccine candidate protects mice against both lethal surrogate Ebola and yellow fever virus challenge

  2023cites this paper
• Targeting the proteases of arboviruses with cyclic and bicyclic peptides

  2023cites this paper
• best investments for the sdg s

  2023cites this paper
• Misclassification of yellow fever vaccination status revealed through hierarchical Bayesian modeling

  2023cites this paper
• A historical perspective on arboviruses of public health interest in Southern Africa

  2023cites this paper
• Tiratricol inhibits yellow fever virus replication through targeting viral RNA-dependent RNA polymerase of NS5.

  2023cites this paper
• Mosquito-borne flaviviruses and type I interferon: catch me if you can!

  2023cites this paper
• Genome-wide analysis and characterization of HSP gene families (HSP20, HSP40, HSP60, HSP70, HSP90) in the yellow fever mosquito (Aedes aegypti) (Diptera: Culicidae)

  2023cites this paper
• Assessing yellow fever outbreak potential and implications for vaccine strategy

  2023influential citation
• A systematic review of the data, methods and environmental covariates used to map Aedes-borne arbovirus transmission risk

  2023cites this paper
• Investigating the impact of social and environmental extremes on cholera time varying reproduction number in Nigeria

  2022cites this paper
• Estimation of yellow fever incidence in Togo between 2010 and 2020.

  2022cites this paper
• LARVICIDAL EFFICACY OF THE SYNERGISTIC COMBINATION OF Allium sativum AND Cymbopogon citratus AGAINST Aedes SPECIES LARVAE

  2022cites this paper
• Laboratory evaluation of RealStar Yellow Fever Virus RT-PCR kit 1.0 for potential use in the global yellow fever laboratory network

  2022cites this paper
• Biodiversity and public health interface

  2022cites this paper
• Yellow fever vaccination coverage among nomadic populations in Savannah region, Ghana; a cross-sectional study following an outbreak

  2022cites this paper
• Mosquito Microbiomes of Rwanda: Characterizing Mosquito Host and Microbial Communities in the Land of a Thousand Hills

  2022cites this paper
• Linear and Machine Learning modelling for spatiotemporal disease predictions: Force-of-Infection of Chagas disease

  2022cites this paper
• Microbes and Infectious Diseases

  2022cites this paper
• Insecticidal effectiveness of naphthalene and its combination with kerosene against the emergence of Aedes aegypti in Ika North East, LGA, Delta State, Nigeria

  2022cites this paper
• Malaria transmission in Africa: Its relationship with yellow fever and measles

  2022cites this paper
• Insights into the Monkeypox virus: making of another pandemic within the pandemic?

  2022cites this paper
• Electrochemiluminescence metal-organic frameworks biosensing materials for detecting cancer biomarkers

  2022cites this paper
• Yellow fever outbreak in Kenya: A review

  2022cites this paper
• Environmental determinants predicting population vulnerability to high yellow fever incidence

  2022cites this paper
• Yellow Fever: Origin, Epidemiology, Preventive Strategies and Future Prospects

  2022cites this paper
• The impact of social and environmental extremes on cholera time varying reproduction number in Nigeria

  2022cites this paper
• The influence of landscape structure on the dispersal pattern of yellow fever virus in the state of São Paulo.

  2022cites this paper
• Nanotechnology’s Promising Role in the Control of Mosquito-Borne Disease

  2022cites this paper
• Impact of yellow fever virus envelope protein on wild-type and vaccine epitopes and tissue tropism

  2022cites this paper
• Spatiotemporal variations in exposure: Chagas disease in Colombia as a case study

  2022influential citation
• Impact of yellow fever virus envelope protein on wild-type and vaccine epitopes and tissue tropism

  2022cites this paper
• An evaluation of the diagnostic performance characteristics of the Yellow Fever IgM immunochromatographic rapid diagnostic test kit from SD Biosensor in Ghana

  2022cites this paper
• Sustained circulation of yellow fever virus in Cameroon: an analysis of laboratory surveillance data, 2010–2020

  2022cites this paper